Comparative Effectiveness Research in Oncology: The Need for Clarity, Transparency and Vision

This publication has 10 references indexed in Scilit:

• American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
  Journal of Clinical Oncology, 2009
• Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond
  British Journal of Cancer, 2009
• The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
  Genetics in Medicine, 2009
• American Society of Clinical Oncology Clinical Practice Guidelines: Opportunities and Challenges
  Journal of Clinical Oncology, 2008
• Impact of a 21‐gene RT‐PCR assay on treatment decisions in early‐stage breast cancer
  Cancer, 2007
• Gene Expression Profile Assays as Predictors of Recurrence-Free Survival in Early-Stage Breast Cancer: A Metaanalysis
  Clinical Breast Cancer, 2006
• Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
  Journal of Clinical Oncology, 2006
• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
  JNCI Journal of the National Cancer Institute, 2005
• A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
  New England Journal of Medicine, 2004
• Methodological challenges in the evaluation of prognostic factors in breast cancer
  Breast Cancer Research and Treatment, 1998